Related MeSH Hierarchy (8)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma, Ovarian Epithelial
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Diseases [C] » Endocrine System Diseases [C19] » Gonadal Disorders » Ovarian Diseases » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Genital Diseases, Female » Adnexal Diseases » Ovarian Diseases » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urogenital Neoplasms » Genital Neoplasms, Female » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Female » Adnexal Diseases » Ovarian Diseases » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Female » Ovarian Neoplasms » Carcinoma, Ovarian Epithelial
Description
A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer. MeSH
Hierarchy View
Approved Indicated Drugs (5)
Phase 4 Indicated Drugs (3)
Phase 2 Indicated Drugs (47)
Phase 1 Indicated Drugs (61)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (17)
Organization Involved with Phase 3 Indications (141)
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
Australia New Zealand Gynaecological Oncology Group
BioNumerik Pharmaceuticals, Inc.
British Columbia Cancer Agency
Cancer and Leukemia Group B (CALGB)
Charité University, Berlin, Germany
Chinese Academy of Medical Sciences
Clinica Universidad de Navarra
Cooperative Ovarian Cancer Group for Immunotherapy Network
Eastern Cooperative Oncology Group
EBMT Solid Tumors Working Party
European Network for Gynaecological Oncological Trial
European Network for Gynaecological Oncological Trial Groups
European Organisation for Research and Treatment of Cancer
Franklin Square Hospital Center
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Grupo Español de Investigación en Cáncer de Ovario
Gynecological Oncology Center South (GOCZ)
Gynecologic Oncology Trial & Investigation Consortium
Hospital general Universitario de Ciudad Real
Huazhong University of Science and Technology
Japanese Gynecologic Oncology Group
Multicenter Italian Trials in Ovarian Cancer
National Cancer Institute (NCI)
National Health and Medical Research Council, Australia
Nordic Society for Gynaecologic Oncology
North Eastern Germany Society of Gynaecologic Oncology
OncoQuest Pharmaceuticals Inc.
People's Liberation Army of China
Organization Involved with Phase 2 Indications (341)
American Society of Clinical Oncology
Asian Gynecologic Oncology Group
Cancer Treatment Research Foundation
Catholic University of Sacred Heart, Rome
Centre Georges Francois Leclerc
Chao Family Comprehensive Cancer Center
City of Hope National Medical Center
East and North Hertfordshire NHS Trust
ECOG-ACRIN Cancer Research Group
European Interbalkan Medical Center
French Cancer Research Hospital Program
Georgia Institute of Technology
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Groupe Hospitalier Diaconesses Croix Saint Simon
Gynecologic Oncology Associates
Gynecologic Oncology Trial and Investigation Consortium, Japan
Hellenic Cooperative Oncology Group
Hellenic Oncology Research Group
Henry M. Jackson Foundation for the Advancement of Military Medicine
Herbert Irving Comprehensive Cancer Center
Hoosier Cancer Research Network
Hospital Universitario Fundación Alcorcón
Hospital Universitari Son Dureta
Icahn School of Medicine at Mount Sinai
Instituto de Medicina Integral Professor Fernando Figueira
Instituto Europeo de Oncologia
James Graham Brown Cancer Center
Jiangsu Cancer Institute & Hospital
Jilin Provincial Tumor Hospital
KK Women's and Children's Hospital
Krankenhaus der Barmherzigen Schwestern Linz
Latin American Cooperative Oncology Group
Ludwig Institute for Cancer Research
Medical University of South Carolina
Memorial Health University Medical Center
Mid-Atlantic Gynecologic Oncology & Pelvic Surgical Associates
National Cheng Kung University
National Comprehensive Cancer Network
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
National University of Singapore
New Mexico Cancer Care Alliance
New York Presbyterian Hospital
Ontario Institute for Cancer Research
Philipps University of Marburg
Royal Marsden Hospital NHS Trust
Russian Academy of Medical Sciences
Samyang Biopharmaceuticals Corporation
San Antonio Military Medical Center
Shanghai Gynecologic Oncology Group
Shenzhen Geno-Immune Medical Institute
Shenzhen Hank Bioengineering Institute
Shenzhen SiBiono GeneTech Co.,Ltd
Southeastern Gynecologic Oncology
South Plains Oncology Consortium
State University of New York, Buffalo
St. Joseph's Hospital and Medical Center - Phoenix, Arizona
The Christie NHS Foundation Trust
The First People's Hospital of Changzhou
The University of Texas, Dallas
Translational Research in Oncology
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
Universitätsklinikum Mannheim, Frauenklinik
University of Alabama, Birmingham
University of California, Irvine
University of California, San Diego
University of California, San Francisco
University of North Carolina at Chapel Hill
University of Southern California
University of Southern Denmark
University of Texas at Houston
University of Texas, San Antonio
University of Western Australia
Vita-Salute University of Milano. Italy
Organization Involved with Phase 1 Indications (87)
Allife Medical Science and Technology Co., Ltd.
Case Western Reserve University
National Hospital Organisation Kyushu Cancer Centre
National Hospital Organisation Shikoku Cancer Centre
Oregon Health and Science University
Shanghai Zhangjiang Biotechnology Limited Company
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
